Skip to content

Menu

LexBlog, Inc. logo
NetworkSub-MenuBrowse by SubjectBrowse by PublisherBrowse by ChannelAbout the NetworkJoin the NetworkProductsSub-MenuProducts OverviewBlog ProBlog PlusBlog PremierMicrositeSyndication PortalsAbout UsContactSubscribeSupport
Book a Demo
Search
Close

Update: Appellate Showdown Over FCA Qui Tam Provision’s Constitutionality Reaches Eleventh Circuit

By Jeremy Burnette & Noam Fischman on January 16, 2025
Email this postTweet this postLike this postShare this post on LinkedIn

As we anticipated in our October 17, 2024, blog, both the Government and the Relator have appealed the district court’s decision in U.S. ex rel. Zafirov v. Florida Medical Associates, LLC, et al. (Zafirov), the first case to hold that the qui tam provision of the federal False Claims Act violates the Appointments Clause of the U.S. Constitution. Briefly, on September 30, 2024, the United States District Court for the Middle District of Florida reasoned that qui tam relators, as whistleblowers, step into the shoes of the federal Government to prosecute such claims. In so doing, the District Court held, relators wield executive power and exercise government authority when litigating FCA claims on the Government’s behalf, thus triggering the Appointments Clause’s requirement that the President, an executive agency department head, or a court appoint them as “officers of the United States.”

Tension exists between this decision and SCOTUS’ June 2023 decision in Polansky (see our blog about that decision here). How can whistleblowers wield executive power and government authority substantial enough to warrant a presidential appointment (Zafirov) when SCOTUS has held that the DOJ can intervene in a qui tam case at any time by merely showing “good cause,” even purely for purposes of dismissing the litigation over the relator’s objection (Polansky)? To do so, the Government need only meet Rule 41’s lenient voluntary dismissal standard.

The Appellants seized upon this tension in their opening Eleventh Circuit briefs. The DOJ cited Polansky to support the Government’s argument that relators do not exercise executive power or government authority sufficient to warrant the Appointments Clause’s requirements. The DOJ argued that it retains the ultimate power of dismissal at all stages of FCA litigation, quoting SCOTUS’ observation in Polansky that district courts should grant the DOJ’s motion to dismiss FCA litigation “in all but the most exceptional cases.”  

Likewise, the Relator (Ms. Zafirov) argued that the DOJ retains “control over every aspect of the [FCA] litigation.” The Relator further minimized the importance of indications in Polansky from Justices Thomas (dissent) and Kavanaugh and Barrett (concurrence) that they would entertain a constitutional challenge to the FCA’s qui tam provision, explaining that their “mere musing” in dicta cannot overtake the consensus of precedent supporting the validity of the whistleblower provision, especially because the remaining six justices did not voice similar constitutional concerns.   

Next up, the Appellees’ response brief is due March 10, 2025. We are eager to see how they respond to the Appellants’ arguments. An ultimate invalidation of the FCA’s qui tam provision on constitutional grounds would completely change the landscape of fraud, waste, and abuse enforcement nationwide. 

Stay tuned for our next update regarding this seismic litigation. 

Photo of Jeremy Burnette Jeremy Burnette

Jeremy Burnette is a seasoned healthcare litigator with substantial experience working within the complex regulatory framework in which providers operate. Jeremy’s practice focuses on representing healthcare providers in a variety of complex litigation matters and disputes, including whistleblower or government investigations or claims…

Jeremy Burnette is a seasoned healthcare litigator with substantial experience working within the complex regulatory framework in which providers operate. Jeremy’s practice focuses on representing healthcare providers in a variety of complex litigation matters and disputes, including whistleblower or government investigations or claims, state licensure board investigations or enforcement actions, government or private payor audit and recoupment actions, medical staff matters, practice dissolutions, and commercial disputes.  Jeremy also advises healthcare providers in regulatory compliance matters and serves as counsel to providers’ internal compliance committees.

Read more about Jeremy BurnetteEmail
Show more Show less
Photo of Noam Fischman Noam Fischman

An experienced healthcare litigator and go-to trial lawyer, Noam Fischman is a trusted guide for healthcare providers, pharmaceutical companies, life sciences companies, and related healthcare vendors, leading clients through cases in federal and state courts, government investigations, and matters involving regulatory agencies. Noam…

An experienced healthcare litigator and go-to trial lawyer, Noam Fischman is a trusted guide for healthcare providers, pharmaceutical companies, life sciences companies, and related healthcare vendors, leading clients through cases in federal and state courts, government investigations, and matters involving regulatory agencies. Noam has a specific focus on managing risk related to fraud and alleged false claims, and fiduciary duty-related issues. He represents hospitals and hospital systems, behavioral health centers, ambulance companies, and skilled nursing facilities.

Read more about Noam FischmanEmail
Show more Show less
  • Posted in:
    Health Care
  • Blog:
    Health Law Rx
  • Organization:
    Akerman LLP
  • Article: View Original Source

LexBlog, Inc. logo
Facebook LinkedIn Twitter RSS
Real Lawyers
99 Park Row
  • About LexBlog
  • Careers
  • Press
  • Contact LexBlog
  • Privacy Policy
  • Editorial Policy
  • Disclaimer
  • Terms of Service
  • RSS Terms of Service
  • Products
  • Blog Pro
  • Blog Plus
  • Blog Premier
  • Microsite
  • Syndication Portals
  • LexBlog Community
  • Resource Center
  • 1-800-913-0988
  • Submit a Request
  • Support Center
  • System Status
  • Resource Center
  • Blogging 101

New to the Network

  • Beyond the First 100 Days
  • In the Legal Interest
  • Cooking with SALT
  • The Fiduciary Litigator
  • CCN Mexico Report™
Copyright © 2025, LexBlog, Inc. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo